Abstract
Intensification of treatment for acute myeloid leukemia (AML) in adult patients resulted in a substantial improvement in long-term prognosis. Therefore, the assessment of quality of life (QL) of patients undergoing treatment is of growing interest. This study was designed to evaluate QL in patients with AML treated according to the protocol of the German AML-Cooperative Group (Münster, Germany). The EORTC QLQ-C 30 questionnaire was used to analyze QL throughout therapy, evaluating defined specific parameters at 12 different time-points. Sixty-one patients were recruited within the first 30 months of the study. Those 28 patients who have completed the course of inpatient treatment (n = 28) are evaluated for changes in the conceptually distinct QL domains: Physical Functioning (P < 0.001), role functioning (P = 0.001), Emotional Functioning (P < 0.001) and social functioning (P = 0.007) improve significantly from beginning of chemotherapy to the end of inpatient treatment. Individual assessment of Global Health Status and Subjective QL improves significantly over the same time (P < 0.001). at the end of inpatient treatment patients suffer significantly less from fatigue, nausea/emesis, loss of appetite and sleep disturbance (P < 0.001). although most patients with aml eventually relapse, the evaluation of ql in patients undergoing treatment shows that subjective benefit outweights the adverse effects of antileukemic therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schumacher, A., Kessler, T., Büchner, T. et al. Quality of life in adult patients with acute myeloid leukemia receiving intensive and prolonged chemotherapy – a longitudinal study. Leukemia 12, 586–592 (1998). https://doi.org/10.1038/sj.leu.2400977
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400977
Keywords
This article is cited by
-
Comparison of quality of life and health behaviors in survivors of acute leukemia and the general population
Annals of Hematology (2019)
-
The impact of remission status on patients’ experiences with acute myeloid leukemia (AML): an exploratory analysis of longitudinal patient-reported outcomes data
Supportive Care in Cancer (2017)
-
The Patient Perspective on Living with Acute Myeloid Leukemia
Oncology and Therapy (2016)
-
Keep your mind off negative things: coping with long-term effects of acute myeloid leukemia (AML)
Supportive Care in Cancer (2016)
-
A pilot phase II RCT of a home-based exercise intervention for survivors of AML
Supportive Care in Cancer (2014)